CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
There is no consensus on the exact role of the adaptive immune system in Parkinson’s disease pathogenesis, although there is increasing evidence that it is somehow involved. Moreover, T cell infiltration in the brain has not been thoroughly studied in Parkinson’s disease and no study has assessed the infiltration in incidental Lewy body diseases cases that are considered to be early presymptomatic stages of the disease. In this study, we performed an immunohistochemistry/immunofluorescence quantitative and phenotypic assessment of T cell infiltration in human substantia nigra pars compacta and analysed the correlations with neuronal death and synucleinopathy throughout different stages of the disease. We included two groups of incidental Lewy disease in the study. One of the groups, which is believed to be the earliest stage of the disease, showed α-synuclein aggregates only in the olfactory bulb. The second group also presented α-synuclein aggregates in the substantia nigra. We also assessed the formation of different α-synuclein aggregates throughout the different stages of the unified staging system for Lewy body disorders (I to IV). We found that CD8 T cells were increased in diagnosed Parkinson’s disease cases compared to the control group and their density positively correlated with neuronal death. Some of the infiltrating CD8 T cells were indeed contacting dopaminergic neurons. No differences were found regarding CD4 T cells. In the earliest stage of the disease, when substantia nigra α-synuclein aggregation is absent, we found a robust CD8 T cell infiltration and no dopaminergic neuronal death yet. Conversely, in the next stage we found neuronal loss and a milder CD8 T cell infiltration. CD8 T cell infiltration paralleled that of α-synuclein accumulation and neuronal death throughout stages II to IV. We also confirmed that CD8 T cells in charge of immune surveillance and involved in the aetiopathogenesis of the disease are equipped with cytolytic enzymes (granzyme A, B and K) and/or proinflammatory cytokines (interferon gamma), and that phenotypic differences were observed between early and late stages of the disease. We also demonstrate that a high proportion of nigral CD8 T cells are tissue resident memory T cells. Our results show that nigral cytotoxic CD8 T cell infiltration is an earlier pathogenic event than α-synuclein aggregation and neuronal death and that it parallels the progression of neuronal death and synucleinopathy in Parkinson’s disease. Overall, our study suggests that CD8 T cell cytotoxic attack may initiate and propagate neuronal death and synucleinopathy in Parkinson’s disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other authors have demonstrated that cytotoxic CD8 + T cell infiltration occurred earlier than a-synuclein aggregation and neuronal death, suggesting adaptive immune system involvement.87”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [87]
Citations
Cites
1 retracted
Chandra, G., Rangasamy, S. B., Roy, A., Kordower, J. H., & Pahan, K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.714824 · Cited by 90
RetractedStaging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Perforin and granzymes: function, dysfunction and human pathology
Voskoboinik, I., Whisstock, J. C., & Trapani, J. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3839 · Cited by 1,327
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K., & Oliveira, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00847 · Cited by 1,224
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
Hamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J., Yearout, D., Kay, D. M., Doheny, K. F., Paschall, J., Pugh, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.642 · Cited by 784
the Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Lue, L., Sue, L. I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Boyer, S., Shirohi, S., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0538-8 · Cited by 698
Understanding Dopaminergic Cell Death Pathways in Parkinson Disease
Michel, P. P., Hirsch, E. C., & Hunot, S. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.038 · Cited by 600
Research works printed but not linked: 1
- Mosley, 2012, Inflammation and adaptive immunity in Parkinson’s disease. Cold Spring Harb, Perspect Med, 2, 1
Cited by
Items 201–292 of 292
Neuroinflammation and Immune Dysfunction in the Mechanisms of Development of Parkinson’s Disease
Idova, G. V., Лазаревна, А. Е., & Zhanaeva, S. Y. (2023) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-023-01549-8 · Cited by 2
“The progression of neurodegradation in PD is associated not only with accumulation of pathological α -syn in brain structures, but also with signi fi cant increases in its serum and CSF levels, indicating the development of a systemic in fl ammatory response and a close relationship between regional neuroin fl ammation a…”
InfluentialPirovano, E., Marino, F., Rossi, E. G., Gennari, A., Rasini, E., Uslenghi, M., Figueira, I., Iacoviello, L., Ferrari, M., & Cosentino, M. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-101946 · Cited by 5
“17 18 Aberrant forms of α -synuclein can stimulate a specific T-cell adaptive response in some PD patients, 19 which seems mediated mainly by IL-4 or IFN γ -producing CD4 + T cells.”
Transcriptional pathobiology and multi-omics predictors for Parkinson’s diseasePreprint
Hu, R., Wang, R., Yuan, J., Lin, Z., Hutchins, E. D., Landin, B., Liao, Z., Liu, G., Scherzer, C. R., & Dong, X. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.18.599639 · Cited by 4
“There are enhanced numbers of both CD4+ and CD8+ T cells in the brain parenchyma which had been observed in neuropathological studies of PD(65–67).”
BackgroundCerebrospinal Fluid Inflammation in Prodromal Parkinson’s DiseasePreprint
Yasumizu, Y., Deerhake, M. E., Corbin-Stein, N. J., Neish, K., Moon, J., Buitrago-Pocasangre, N., Renkl, E., Esposito, S., Russo, A. J., Wang, H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.16.654530 · Cited by 3
Kimura, K. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00760 · Cited by 1
“CD8 + Trm cells infiltrate the substantia nigra of patients with PD at the earliest stages of the disease, preceding the formation of a-synuclein aggregation and dopaminergic neuronal death (Galiano-Landeira et al., 2020).”
Lead Phytomolecules for Treating Parkinson’s Disease
Agrawal, K. K., Veer, C., Murti, Y., & Singh, S. P. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249355503241210101001 · Cited by 1
Idova, G. V., Zhanaeva, S. Y., Лазаревна, А. Е., Dzemidovich, S. S., Gevorgyan, M. M., Kulikova, K. I., & Aftanas, L. I. (2025) · Biochemistry (Moscow) · doi:10.1134/s0006297925600334 · Cited by 1
Increased peripheral CD4+ lymphocytes promote ketamine-induced abnormal behaviors in mice
Hu, J., Wang, P., Lin, Y., Jiang, Z., Zhang, Y., Shi, K., Wen, D., Ma, C., Liao, L., & Wang, X. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115337 · Cited by 1
Burgaz, S., Rodríguez-Carreiro, S., Navarro, E., Lastres‐Becker, I., García-Arencibia, M., Palomo‐Garo, C., Gómez‐Gálvez, Y., Gómez‐Cañas, M., García, C., & Fernández‐Ruíz, J. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-025-00016-7 · Cited by 1
“For example, a relevant contribution of the peripherally located CB 2 R is supported by studies showing the ability of circulating cells (lymphocytes, monocytes) to infiltrate the brain in PD [146, 147].”
Intonti, S., Enzmann, V., Perna, A., Spagnolo, F., Curcio, C., & Conedera, F. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020965 · Cited by 1
“These findings provide a mechanistic rationale for temporally targeted immunomodulation that curbs chronic CD8 + and reactive gliosis while preserving early CD4 trophic support, a strategy also supported by recent murine and human evidence (37, 47).”
InfluentialKaul, S., Vulli, A., & Kalivendi, S. V. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112399 · Cited by 1
Cellular and Molecular Mechanisms Contributing to Parkinson’s Disease
Madhuranthagan, M., Benito Johnson., D., Essly Selva Jasmine., P., Suresh., R., & Senthil Kumar., C. (2026) · Research Journal of Pharmacology and Pharmacodynamics · doi:10.52711/2321-5836.2026.00005 · Cited by 1
Zhao, J., Liang, H., & Bi, Y. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111990 · Cited by 1
Hakami, M. A., Fatima, R., Khan, Y., Alsaiari, A. A., Alsaiari, J. A., & Hussain, M. S. (2026) · EXCLI journal · doi:10.17179/excli2026-9572 · Cited by 1
Jasak, P., Wesołowska, A., Żółtowska, M., Alster, P., & Madetko‐Alster, N. (2026) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2026.108917 · Cited by 1
Yang, W., Chen, Z., Zhang, Y., Peng, C., & Chen, B. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1893517 · Cited by 1
Fawzy, M. N. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02363-7 · Cited by 2
“Furthermore, postmortem brains of individuals with PD display an accumulation of CD8⁺ T cells surrounding dopaminergic neurons in the substantia nigra (Ma et al. 2025; Galiano-Landeira et al. 2020).”
Immune response during idiopathic Parkinson's disease: From humans to animal models
Nissen, S. K., Ferreira, S. A., Klæstrup, I. H., & Romero‐Ramos, M. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.08.006 · Cited by 1
Parkinson- und Alzheimer-Erkrankung als Systemerkrankungen
Bartsch, T., Berg, D., Heneka, M. T., & Leypoldt, F. (2023) · Der Nervenarzt · doi:10.1007/s00115-023-01542-z · Cited by 2
“Neuere Daten weisen insbe-sondere in Richtung der T-Lymphozyten als mögliche Effektoren bei primär neuro-degenerativen Erkrankungen ( .”
InfluentialNEUROINFLAMMATION AND IMMUNE DYSFUNCTION IN THE PATHOGENESIS OF PARKINSON’S DISEASE
Idova, G. V., Лазаревна, А. Е., & Zhanaeva, S. Y. (2023) · Журнал высшей нервной деятельности им И П Павлова · doi:10.31857/s0044467723040056 · Cited by 2
Church, K. A., Cardona, A. E., & Hopp, S. C. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_15 · Cited by 1
Brain-Resident CD8 + T Cells Regulate Neuronal Activity and Behavior via Interferon-GammaPreprint
Park, K., Jang, J., Jeon, S., Hwang, S., Choi, K., cox, T., Ngiow, S. F., flores, J., Harrison, C. F., Liu, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.24.746768 · Cited by 1
Wu, Z., Zhang, X., Xia, Y., & Hu, Z. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4053375
Comino, A., Antolín‐Vallespín, M., López-Benito, A., Muñoz, G., del Castillo, F. J., Vela, L., Martínez‐Castrillo, J. C., & Sánchez‐Capelo, A. (2022) · medRxiv · doi:10.1101/2022.07.09.22277447
Fredlund, F., Jiménez-Ferrer, I., Grabert, K., Belfiori-Carrasco, L. F., Luk, K. C., & Swanberg, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.02.518821
“Although recent genetic studies point at MHCII, but not MHCI, genes associated to PD [7], neuronal MHCI expression [35], CD8+ T lymphocyte infiltration [36] and reactivity to -Syn [11] could potentially play a role in PD susceptibility.”
BackgroundРоль Т-клеточных субпопуляций в патогенезе и терапии болезни Паркинсона (обзор литературы)
Idova, G. V., Лазаревна, А. Е., & Zhanaeva, S. Y. (2023) · Сибирский вестник психиатрии и наркологии · doi:10.26617/1810-3111-2023-1(118)-96-103
Study of the immunopathogenesis of narcolepsy type-1 using original mouse models
Frieser, D. (2022) · theses.fr (ABES) · doi:10.70675/02b7c749z929fz4542za4c5z956b592bf2e1
Chen, Z., Li, G., Zhou, L., Zhang, L., You, Y., & Liu, J. (2024) · Research Square · doi:10.1101/2024.05.03.24306837
Han, Q., Luo, X., Zhang, S., Zhou, Z., Wang, L., Li, J., & Zhang, B. (2024) · Research Square · doi:10.21203/rs.3.rs-4823563/v1
Immunity, Immunosenescence, Brain and Cognitive/Mental Health
Fülöp, T., & Witkowski, J. M. (2024) · Healthy ageing and longevity · doi:10.1007/978-3-031-68513-2_6
Crosstalk Between the Immune and Nervous Systems
Vedam‐Mai, V. (2024) · Neuromethods · doi:10.1007/978-1-0716-4083-8_3
Liblau, R. (2025) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2024.11.026
Kelly, C., Milner, J. P., Lester, B. A., Brindley, S., Hernández, L. P., Biswas, S. R., Murdaugh, L. B., Wei, X., Dixon, C. J., Olsen, M. L., et al. (2026) · Journal of Neuroinflammation · doi:10.1101/2025.09.16.676659
A Spatially Resolved View on the Aging Substantia nigra: An Exploratory Proteomic Study
Eggers, B., Hausherr, M., Lim, M., Schork, K., Karacora, B., Grugel, R., Eisenacher, M., Aldea, I. G., Riederer, P. F., Gerlach, M., et al. (2025) · Advanced Biology · doi:10.1002/adbi.202500358 · Cited by 1
The Neuroimmune Landscape of the Lysosomal Storage Disorder Sanfilippo Syndrome
Badell‐Grau, R. A., & Schlachetzki, J. C. M. (2025) · BioEssays · doi:10.1002/bies.70083 · Cited by 1
Immunopathogenesis of Parkinson’s Disease: From Peripheral Inflammation to Neurodegeneration
Aakash, A., Abdalla, A., Ismail, H., malik, M. K., Ghani, M. U., Ahmed, M., el Hamid, A. S. A., & Rathi, L. (2025) · Journal of Carcinogenesis · doi:10.64149/j.carcinog.24.10s.28-33
CNS-11g reduces α-synuclein pathology and restores motor function in a Parkinson’s modelPreprint
Frautschy, S. A., Manglani, K., Zuo, X., Zhu, C., Jones, M. R., Bombino, A., Pan, H., Hou, K., Kwon, J. M., Teter, B., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7935366/v1
Neuromelanin: Bridging catecholamine metabolism and neurodegeneration in Parkinson's disease
González-Sepúlveda, M., Cladera-Sastre, J. M., & Vila, M. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-21992-4.00002-6 · Cited by 1
Self-citationBérard, M., Martínez-Drudis, L., Sheta, R., El‐Agnaf, O. M. A., & Oueslati, A. (2024) · Figshare · doi:10.6084/m9.figshare.26645842
Bérard, M., Martínez-Drudis, L., Sheta, R., El‐Agnaf, O. M. A., & Oueslati, A. (2024) · Figshare · doi:10.6084/m9.figshare.26645827
Bérard, M., Martínez-Drudis, L., Sheta, R., El‐Agnaf, O. M. A., & Oueslati, A. (2024) · Figshare · doi:10.6084/m9.figshare.26645830
Bérard, M., Martínez-Drudis, L., Sheta, R., El‐Agnaf, O. M. A., & Oueslati, A. (2024) · Figshare · doi:10.6084/m9.figshare.26645824
Bérard, M., Martínez-Drudis, L., Sheta, R., El‐Agnaf, O. M. A., & Oueslati, A. (2024) · Figshare · doi:10.6084/m9.figshare.26645818
Bérard, M., Martínez-Drudis, L., Sheta, R., El‐Agnaf, O. M. A., & Oueslati, A. (2023) · Figshare · doi:10.6084/m9.figshare.24647135
Bérard, M., Martínez-Drudis, L., Sheta, R., El‐Agnaf, O. M. A., & Oueslati, A. (2024) · Figshare · doi:10.6084/m9.figshare.26645812
Bérard, M., Martínez-Drudis, L., Sheta, R., El‐Agnaf, O. M. A., & Oueslati, A. (2024) · Figshare · doi:10.6084/m9.figshare.26645821
Wang, Y., Shen, Y., Liang, J., Wang, S., Huang, Y., Zhu, Q., Zhang, X., Yu, K., Tong, G., Yang, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25770489
Wu, C.-T., Chu, C.-I., Wang, F.-Y., Yang, H.-Y., Tseng, W.-S., Chang, C.-R., & Chang, C.-C. (2022) · Figshare · doi:10.6084/m9.figshare.21256882
Bérard, M., Martínez-Drudis, L., Sheta, R., El‐Agnaf, O. M. A., & Oueslati, A. (2024) · Figshare · doi:10.6084/m9.figshare.24647350
Bérard, M., Martínez-Drudis, L., Sheta, R., El-Agnaf, O. M. A., & Oueslati, A. (2024) · Figshare · doi:10.6084/m9.figshare.26645836
Bérard, M., Martínez-Drudis, L., Sheta, R., El‐Agnaf, O. M. A., & Oueslati, A. (2024) · Figshare · doi:10.6084/m9.figshare.26645815
Skidmore, S. (2023) · Apollo (University of Cambridge) · doi:10.17863/cam.99788
Bérard, M., Martínez-Drudis, L., Sheta, R., El‐Agnaf, O. M. A., & Oueslati, A. (2024) · Figshare · doi:10.6084/m9.figshare.26645839
Wang, Y., Shen, Y., Liang, J., Wang, S., Huang, Y., Zhu, Q., Zhang, X., Yu, K., Tong, G., Yang, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25770390
Bérard, M., Martínez-Drudis, L., Sheta, R., El‐Agnaf, O. M. A., & Oueslati, A. (2024) · Figshare · doi:10.6084/m9.figshare.26645833
Meng, G., Pan, Y., Tang, W., Zhang, L., Cui, Y., Schumacher, F. R., Wang, M., Wang, R., He, S., Krischer, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25720104
Sex-based modulation of neuromelanin-linked Parkinson's disease pathology
Guillard-Sirieix, C. (2024) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Metzdorf, J. (2025) · Dokumentenrepositorium der RUB (Ruhr University Bochum) · doi:10.13154/294-12588
Parkinson’s Disease and Gut Microbiota
Swathi, N. L., Umar, T. P., Elenien, W. I. A., Bhagat, S., Sakini, A. S. A., & Nand, S. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-2104-3_6
Microbiota effects in a Pink1-/- mouse model of infection-induced Parkinson’s disease
Brouillard-Galipeau, M. (2024) · eScholarship@McGill (McGill) · doi:10.82308/44945
PISTONE, A. (2026) · CINECA IRIS Institutional Research Information System (University of Basilicata)
CD8⁺ T cells induce interstrand crosslinking-associated DNA damage in neuronsPreprint
Blackhurst, B. M., Bhatt, A., Kretchmer, E., Tucker, A. E., Kurtz, B., Reagin, K. L., & Funk, K. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.14.711737
Paul, K., Wilkins, O. M., Carloni, E., Fikse, E. N., Salas, L. A., Lee, S., Feldman, M. S., Thompson, R., Kersey, G. E., Jeffreys, C. A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.30.715379
“…90,91 , including activated CD8+ T cells and CD14+ monocytes, and subsequent close interaction with the CNS. Infiltrating T cells have been found near degenerating DA neurons in the substantia nigra 92 , and infiltrating monocytes are associated with α-syn-induced neuroinflammation 16 .”
Role of T-cell immunity in the pathophysiology of Alzheimer’s disease and other Tauopathies
Matta, K. (2024) · theses.fr (ABES) · doi:10.70675/cea4fe5ez67c3z4445z92f7z39af62ba059b
Cause, consequence, or synergy: the role of T-cell infiltration across neurodegenerative diseases
Cullinane, P. W., Nelvagal, H. R., Wong, C., Curless, T. J., Baranauskienė, G., Jurkevičienė, J., Farin, Z., Pimparkar, S., Bechtawi, M., Chiraki, N., et al. (2026) · Brain · doi:10.1093/brain/awag143
Zhao, J., Fu, J., Zhang, J., Zhang, Z., Bai, X., & Yao, L. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10236-1
“CD8⁺ T cells—particularly effector memory (TEM) subsets—have been suggested to contribute to neuroinflammation through early substantia nigra infiltration and granzyme B/IFN-γ production (Galiano-Landeira et al. 2020).”
Engineered Exosomes: Innovative Strategies for Precision Drug Delivery in Parkinson’s Disease
Yuan, X., Wang, C., Yan, J., Wang, J., Li, F., You, Y., & Qi, Z. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05898-6
“…compromises the integrity of the blood–brain barrier (BBB), permitting infiltration of peripheral immune cells and exacerbating the neurotoxic milieu, a process that can be further intensified by pathogenic LRRK2 signaling linked to vesicular trafficking and immune dysregulation [18–21].”
Vacchi, E., Burrello, J., Burrello, A., Bolis, S., Ruíz‐Barrio, I., Bertaina, I., Baldelli, L., Bacalini, M. G., Chiaro, G., Kaelin, R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.12.724498
Peripheral Immunological Signatures of Parkinsonism: Insights from the Caribbean vs. North America
Chaumont, H., Coquelet, P., Balthazard, R., Tressières, B., Chaumont, J., Ravion, S., Gaëte, S., Carpentier, A. V., Duquette, A., Andriamboavonjy, L., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05919-4
“CD8 + and CD4 + T cells have been implicated in the pathobiology of PD as potential initiators and propagators of neuronal death and synucleinopathy, based on findings from both peripheral samples and postmortem brain tissues [27, 29, 52].”
Microglial Foxo3 shapes dopaminergic vulnerability in Parkinson’s diseasePreprint
Texier, B., Roudaud, S., Husson, Q., Prime, M., Alma, M., Dominguez-Coronado, L., Frieser, D., Dorze, A.-L. L., Zahm, M., Iscache, A.-L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.727098 · Cited by 1
Nannoni, M. (n.d.) · BOA (University of Milano-Bicocca)
Csf1r-mediated depletion of myeloid cells prevents dopaminergic neuron loss during chronic colitis
Kutscherauer, R. K., Andert, M., Stolzer, I., Neumaier, E. E., Dedden, M., Kielkowski, P., Xiang, W., Grotemeyer, A., Prinz, M., Masuda, T., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03926-9
“Also in PD, CD8 + T cells are present in the substantia nigra early in disease and may contribute to dopaminergic neuron loss [63, 64].”
Guo, Y., Liu, W., Bu, W., Wang, R., Su, D., & Li, H. (2026) · BMC Neurology · doi:10.1186/s12883-026-05109-8
Swann, P., Malpetti, M., Chouliaras, L., White, S. R., Mak, E., Surendranathan, A., Jones, P. S., Su, L., Savulich, G., Kigar, S. L., et al. (2026) · Brain Communications · doi:10.1093/braincomms/fcag274
Rumpf, S.-L., Struebing, F. L., Nalbach, K., Vargiu, C. M., Berg, G., Lichtenthaler, S. F., Parchi, P., Gao, P., Weilin, C. H. E. N., Brendel, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74961-6
Nguyễn, H. Đ., Lee, S., Ma, H., Kim, Y. J., Kim, Y. E., & Kim, Y. E. (2026) · Movement Disorders · doi:10.1002/mds.70443
Converging pathomechanisms link SARS-CoV-2 infection with major neurodegenerative diseases
HeFeng, F. Q., Martí-Sarrias, A., Ataş, H., de Sá, R. V., Sridhar, A., Haferkamp, U., Kach-Marso, F. E., Bauermeister, S., Hudák, A., Roubanis, A., et al. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01785-9
Grandke, F., Diener, C., Becher, B., Becker, A., Ludwig, N., Walch‐Rückheim, B., Tänzer, T., Dillmann, K.-U., Hart, M., Unger, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.13.744357
Serum Granzyme B in Parkinson’s Disease: A Case–Control Study of Diagnostic Association
Almulhim, M. F., Elgamal, S., Ghazy, A. A., Mohamed, S. A. S., Eissa, S. A., Shatara, S. A. F., Shatara, Y. A., Rashwan, E. K., & Ismail, M. A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15187115
Even, A., Mukherjee, S., Giguère, N., Brouillard-Galipeau, M., Oliveira, N. L., Halder, P., Beaulieu, C., Cayrol, R., Berge, N. V. D., Gruenheid, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.22.753365
Gallus, M., Khan, S. H., Zhao, A., Benway, H., Lu, J., Nejo, T., Watchmaker, P. B., & Okada, H. (2026) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-026-00944-8
Żółtowska, M., Wesołowska, A., Jasak, P., Madetko‐Alster, N., & Alster, P. (2026) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.112255
Yang, D., Choi, S., Piao, J., Evangelisti, A., Yang, Z., Bocchi, V. D., Donohue, S. A., Claros, N., Jungverdorben, J., Sidharta, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.23.753784
Role of T cells in Parkinson’s disease
Koops, D., Lehmann, R., Bianchi, F., & van den Bogaart, G. (2026) · BMJ Immunology · doi:10.1136/bmjimm-2026-000039
Gruden, M. A., & Sewell, R. D. E. (2022) · Nauchno-prakticheskii zhurnal «Patogenez» · doi:10.25557/2310-0435.2022.03.18-23
Castro, J., Jiménez, J. M., Elgueta, D., Chovar, O., Ugalde-Tagle, V., Martínez, N., Cea, J., Espinoza, A., Mora, J., Valenzuela, S., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10670304/v1
Metabolic regulation of T cells in neuroinflammation
Mir, P. A., Bhutia, G. T., Kumar, N., Uppal, J., & Gupta, S. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44253-7.00005-9
Gong, D., Li, G., Li, M., Zhang, B., Wang, W., Chen, J., & Zhao, Y. (2026) · PLoS ONE · doi:10.1371/journal.pone.0362081
Metadata
- Authors
- Galiano-Landeira, J., Torra, A., Vila, M., & Bové, J.
- Affiliations
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Corresponding author
- Bové, Jordi
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-10-29
- Volume
- 143
- Issue
- 12
- Pages
- 3717-3733
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W3096763885
- Cited by
- 267
- References
- 62
- Citations by year
- 2026: 43 · 2025: 51 · 2024: 64 · 2023: 46 · 2022: 42 · 2021: 20 · 2020: 1
- FWCI
- 11.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fondo de Investigación Sanitaria-Instituto de Salud Carlos III (PI15/01937, PI18/01894)
- European Union, and Pla Estratègic de Recerca i Innovació en salut-Departament de Salut Generalitat de Catalunya (SLT006/17/00258)
- Ministry of Economy and Competitiveness (SAF2016-77541-R)
- “la Caixa” Foundation (100010434, LCF/PR/HR17/52150003)
- Fondo de Investigación Sanitaria- Instituto de Salud Carlos III
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- CD8+ T cells, T cell infiltration, substantia nigra pars compacta, synucleinopathies, alpha-synuclein aggregation, dopaminergic neuron loss, incidental Lewy body disease, tissue-resident memory T cells, granzymes, interferon-gamma, adaptive immune response, neuroinflammation, cytotoxic T lymphocytes, presymptomatic disease
- MeSH terms
- Synucleinopathies, Aged, Aged, 80 and over, Brain, Cytotoxins, Female, Humans, Immunohistochemistry, Immunologic Surveillance, Male, Neurons, Parkinson Disease, Substantia Nigra, Cytokines, Cell Death, CD8-Positive T-Lymphocytes, Disease Progression, Lewy Body Disease, alpha-Synuclein, Granzymes, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.